English

GRIDIRON BIONUTRIENTS, INC.

EDGAR

Quarterly report (10-Q) · filed 2025-05-06

40 filing records in this dataset, filed from 2015-04-13 to 2025-05-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

151 thousand USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 150920 USD Source

Cash and cash equivalents: 108 thousand USD 2024-02-29 Source
Exact value

107527 USD
Long-term debt including current maturities: Not available
Shares outstanding: 22.5 million shares 2024-02-29 Source
Exact value

22470239 shares

Reported share-count change

12.24% · 2.45 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

20020239 shares · 2023-02-28· Source
22470239 shares · 2024-02-29· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2022-12-01 – 2023-11-30

Exact inputs and evidence

Revenue: 0 USD · 2022-12-01 – 2023-02-28 Source
Revenue: 0 USD · 2023-03-01 – 2023-05-31 Source
Revenue: 0 USD · 2022-09-01 – 2023-08-31 Source
Revenue: 0 USD · 2022-09-01 – 2023-05-31 Source
Revenue: 0 USD · 2023-09-01 – 2023-11-30 Source

Net income

-5.3 million USD

2023-03-01 – 2024-02-29

Exact inputs and evidence

Net income: -298857 USD · 2023-03-01 – 2023-05-31 Source
Net income: -4454352 USD · 2023-06-01 – 2023-08-31 Source
Net income: -255228 USD · 2023-09-01 – 2023-11-30 Source
Net income: -289744 USD · 2023-12-01 – 2024-02-29 Source

Operating cash flow

-515 thousand USD

2023-03-01 – 2024-02-29

Exact inputs and evidence

Operating cash flow: -593320 USD · 2022-09-01 – 2023-05-31 Source
Operating cash flow: -404010 USD · 2022-09-01 – 2023-02-28 Source
Operating cash flow: -620195 USD · 2022-09-01 – 2023-08-31 Source
Operating cash flow: -593320 USD · 2022-09-01 – 2023-05-31 Source
Operating cash flow: 150920 USD · 2023-09-01 – 2023-11-30 Source
Operating cash flow: -299212 USD · 2023-09-01 – 2024-02-29 Source
Operating cash flow: 150920 USD · 2023-09-01 – 2023-11-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-06.

Financial data available through: 2023-08-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2023-08-31
Operating income: 6 of 11 periods available· newest 2023-08-31
Net income: 9 of 11 periods available· newest 2023-08-31
Operating cash flow: 9 of 11 periods available· newest 2023-08-31
Capital expenditure: 4 of 11 periods available· newest 2023-08-31
Total assets: 6 of 11 periods available· newest 2023-08-31
Total liabilities: 4 of 11 periods available· newest 2023-08-31
Current assets: 6 of 11 periods available· newest 2023-08-31
Current liabilities: 6 of 11 periods available· newest 2023-08-31
Cash and cash equivalents: 6 of 11 periods available· newest 2023-08-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2023-08-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2021-09-01 – 2022-08-31
Current period

USD 0

2022-09-01 – 2023-08-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2021-09-01 – 2022-08-31
Inspect prior input Prior source
0 USD · 2022-09-01 – 2023-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#334949 Filing: 000147793224000223 Input fundies:Revenue: 0 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#335504 Filing: 000147793224000223
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 34.89 million

Prior period

−USD 40.88 million

2021-09-01 – 2022-08-31
Current period

−USD 5.99 million

2022-09-01 – 2023-08-31

Exact inputs and evidence

-5988266 − -40877813 = 34889547 USD

-40877813 USD · 2021-09-01 – 2022-08-31
Inspect prior input Prior source
-5988266 USD · 2022-09-01 – 2023-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Year-over-year change in Net income: 34889547 USD Concept: fundies:NetIncome Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -5988266 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#662931 Filing: 000147793224000223 Input fundies:NetIncome: -40877813 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#663463 Filing: 000147793224000223
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.51 million

Prior period

−USD 3.13 million

2021-09-01 – 2022-08-31
Current period

−USD 620,195

2022-09-01 – 2023-08-31

Exact inputs and evidence

-620195 − -3127852 = 2507657 USD

-3127852 USD · 2021-09-01 – 2022-08-31
Inspect prior input Prior source
-620195 USD · 2022-09-01 – 2023-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Year-over-year change in Operating cash flow: 2507657 USD Concept: fundies:OperatingCashFlow Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -620195 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#690040 Filing: 000147793224000223 Input fundies:OperatingCashFlow: -3127852 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#690721 Filing: 000147793224000223
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 3,138

2021-09-01 – 2022-08-31
Current period

USD 0

2022-09-01 – 2023-08-31

Exact inputs and evidence

0 − 3138 = -3138 USD

3138 USD · 2021-09-01 – 2022-08-31
Inspect prior input Prior source
0 USD · 2022-09-01 – 2023-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Year-over-year change in Capital expenditure: -3138 USD Concept: fundies:CapitalExpenditure Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#693817 Filing: 000147793224000223 Input fundies:CapitalExpenditure: 3138 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#694459 Filing: 000147793224000223
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2022-09-01 – 2023-08-31

Revenue USD 0
Cost of revenue USD 0
Operating expenses USD 1.37 million
Other operating costs Derived USD 0
Operating income −USD 1.37 million
Tax, interest and other Derived USD 4.62 million
Net income −USD 5.99 million

Cash

Operating cash flow −USD 620,195
Capital expenditure USD 0
Free cash flow Derived −USD 620,195

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 2,700% of revenue.
2019 Operating loss: operating costs were 891% of revenue.
2020 Operating loss: operating costs were 18,464% of revenue.
2021 Operating loss: operating costs were 8,491% of revenue.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2017-09-01 – 2018-08-31	16771	452889 Derived	-436118	539406 Derived	-975524	-445029 Derived	Source 2017-09-01 – 2018-08-31: 16771 USD Inspect Revenue Open source 2017-09-01 – 2018-08-31: -436118 USD Inspect Operating Income Open source 2017-09-01 – 2018-08-31: -975524 USD Inspect Net Income Open source 2017-09-01 – 2018-08-31: -442562 USD Inspect Operating Cash Flow Open source 2017-09-01 – 2018-08-31: 2467 USD Inspect Capital Expenditure Open source
2019 2018-09-01 – 2019-08-31	79246	705977 Derived	-626731	-456664 Derived	-170067	Unavailable	Source 2018-09-01 – 2019-08-31: 79246 USD Inspect Revenue Open source 2018-09-01 – 2019-08-31: -626731 USD Inspect Operating Income Open source 2018-09-01 – 2019-08-31: -170067 USD Inspect Net Income Open source 2018-09-01 – 2019-08-31: -775929 USD Inspect Operating Cash Flow Open source
2020 2019-09-01 – 2020-08-31	1181	218058 Derived	-216877	2363191 Derived	-2580068	Unavailable	Source 2019-09-01 – 2020-08-31: 1181 USD Inspect Revenue Open source 2019-09-01 – 2020-08-31: -216877 USD Inspect Operating Income Open source 2019-09-01 – 2020-08-31: -2580068 USD Inspect Net Income Open source 2019-09-01 – 2020-08-31: -410248 USD Inspect Operating Cash Flow Open source
2021 2020-09-01 – 2021-08-31	3080	261521 Derived	-258441	-1298373 Derived	1039932	-30405 Derived	Source 2020-09-01 – 2021-08-31: 3080 USD Inspect Revenue Open source 2020-09-01 – 2021-08-31: -258441 USD Inspect Operating Income Open source 2020-09-01 – 2021-08-31: 1039932 USD Inspect Net Income Open source 2020-09-01 – 2021-08-31: -30405 USD Inspect Operating Cash Flow Open source 2020-09-01 – 2021-08-31: 0 USD Inspect Capital Expenditure Open source
2022 2021-09-01 – 2022-08-31	0	5249745 Derived	-5249745	35628068 Derived	-40877813	-3130990 Derived	Source 2021-09-01 – 2022-08-31: 0 USD Inspect Revenue Open source 2021-09-01 – 2022-08-31: -5249745 USD Inspect Operating Income Open source 2021-09-01 – 2022-08-31: -40877813 USD Inspect Net Income Open source 2021-09-01 – 2022-08-31: -3127852 USD Inspect Operating Cash Flow Open source 2021-09-01 – 2022-08-31: 3138 USD Inspect Capital Expenditure Open source
2023 2022-09-01 – 2023-08-31	0	1367386 Derived	-1367386	4620880 Derived	-5988266	-620195 Derived	Source 2022-09-01 – 2023-08-31: 0 USD Inspect Revenue Open source 2022-09-01 – 2023-08-31: -1367386 USD Inspect Operating Income Open source 2022-09-01 – 2023-08-31: -5988266 USD Inspect Net Income Open source 2022-09-01 – 2023-08-31: -620195 USD Inspect Operating Cash Flow Open source 2022-09-01 – 2023-08-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-08-31	Revenue	16771	Revenue: 16771 Open source
20192019-08-31	Revenue	79246	Revenue: 79246 Open source
20202020-08-31	Revenue	1181	Revenue: 1181 Open source
20212021-08-31	Revenue	3080	Revenue: 3080 Open source
20222022-08-31	Revenue	0	Revenue: 0 Open source
20232023-08-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-08-31	Year over year	No prior comparable period	Revenue: 16771 Open source
20192019-08-31	Year over year	372.5%	Revenue: 79246 Open source Revenue: 16771 Open source
20202020-08-31	Year over year	-98.5%	Revenue: 1181 Open source Revenue: 79246 Open source
20212021-08-31	Year over year	160.8%	Revenue: 3080 Open source Revenue: 1181 Open source
20222022-08-31	Year over year	-100%	Revenue: 0 Open source Revenue: 3080 Open source
20232023-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -8,390.9% 2021

Net margin 33,764% 2021

Free cash flow margin -987.2% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-08-31	Operating margin	-2,600.4%	Operating Income: -436118 Open source Revenue: 16771 Open source
20192019-08-31	Operating margin	-790.9%	Operating Income: -626731 Open source Revenue: 79246 Open source
20202020-08-31	Operating margin	-18,363.8%	Operating Income: -216877 Open source Revenue: 1181 Open source
20212021-08-31	Operating margin	-8,390.9%	Operating Income: -258441 Open source Revenue: 3080 Open source
20222022-08-31	Operating margin	Not reported	Operating Income: -5249745 Open source Revenue: 0 Open source
20232023-08-31	Operating margin	Not reported	Operating Income: -1367386 Open source Revenue: 0 Open source
20182018-08-31	Net margin	-5,816.7%	Net Income: -975524 Open source Revenue: 16771 Open source
20192019-08-31	Net margin	-214.6%	Net Income: -170067 Open source Revenue: 79246 Open source
20202020-08-31	Net margin	-218,464.7%	Net Income: -2580068 Open source Revenue: 1181 Open source
20212021-08-31	Net margin	33,764%	Net Income: 1039932 Open source Revenue: 3080 Open source
20222022-08-31	Net margin	Not reported	Net Income: -40877813 Open source Revenue: 0 Open source
20232023-08-31	Net margin	Not reported	Net Income: -5988266 Open source Revenue: 0 Open source
20182018-08-31	Free cash flow margin	-2,653.6%	Revenue: 16771 Open source Operating Cash Flow: -442562 Open source Capital Expenditure: 2467 Open source
20192019-08-31	Free cash flow margin	Not reported	Revenue: 79246 Open source Operating Cash Flow: -775929 Open source
20202020-08-31	Free cash flow margin	Not reported	Revenue: 1181 Open source Operating Cash Flow: -410248 Open source
20212021-08-31	Free cash flow margin	-987.2%	Revenue: 3080 Open source Operating Cash Flow: -30405 Open source Capital Expenditure: 0 Open source
20222022-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -3127852 Open source Capital Expenditure: 3138 Open source
20232023-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -620195 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -620.2K 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-08-31	Operating cash flow	-442562	Operating Cash Flow: -442562 Open source
20192019-08-31	Operating cash flow	-775929	Operating Cash Flow: -775929 Open source
20202020-08-31	Operating cash flow	-410248	Operating Cash Flow: -410248 Open source
20212021-08-31	Operating cash flow	-30405	Operating Cash Flow: -30405 Open source
20222022-08-31	Operating cash flow	-3127852	Operating Cash Flow: -3127852 Open source
20232023-08-31	Operating cash flow	-620195	Operating Cash Flow: -620195 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -620.2K 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-08-31	Free cash flow	-445029	Operating Cash Flow: -442562 Open source Capital Expenditure: 2467 Open source
20192019-08-31	Free cash flow	Unavailable	Operating Cash Flow: -775929 Open source
20202020-08-31	Free cash flow	Unavailable	Operating Cash Flow: -410248 Open source
20212021-08-31	Free cash flow	-30405	Operating Cash Flow: -30405 Open source Capital Expenditure: 0 Open source
20222022-08-31	Free cash flow	-3130990	Operating Cash Flow: -3127852 Open source Capital Expenditure: 3138 Open source
20232023-08-31	Free cash flow	-620195	Operating Cash Flow: -620195 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

4,613.5% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2018-08-31	Liabilities / assets	Not reported	Total Assets: 862743 Open source
2019-08-31	Liabilities / assets	Not reported	Total Assets: 256414 Open source
20202020-08-31	Liabilities / assets	1,383.8%	Total Liabilities: 2886610 Open source Total Assets: 208603 Open source
20212021-08-31	Liabilities / assets	223.6%	Total Liabilities: 406725 Open source Total Assets: 181886 Open source
20222022-08-31	Liabilities / assets	93.5%	Total Liabilities: 41110839 Open source Total Assets: 43963413 Open source
20232023-08-31	Liabilities / assets	4,613.5%	Total Liabilities: 3505956 Open source Total Assets: 75993 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20182018-08-31	Current assets / current liabilities	1.25×	Current Assets: 858006 Open source Current Liabilities: 686868 Open source
20192019-08-31	Current assets / current liabilities	1.11×	Current Assets: 248149 Open source Current Liabilities: 224053 Open source
20202020-08-31	Current assets / current liabilities	0.07×	Current Assets: 202128 Open source Current Liabilities: 2886610 Open source
20212021-08-31	Current assets / current liabilities	0.41×	Current Assets: 168476 Open source Current Liabilities: 406725 Open source
20222022-08-31	Current assets / current liabilities	0.01×	Current Assets: 286956 Open source Current Liabilities: 29812416 Open source
20232023-08-31	Current assets / current liabilities	0.02×	Current Assets: 72744 Open source Current Liabilities: 3286957 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2014-09-01 – 2015-08-31	−USD 14,523 Exact value Exact value: -14523 USD 2014-09-01 – 2015-08-31: -14523 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2015-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -14523 USD Concept: fundies:NetIncome Period: 2014-09-01 to 2015-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2015-08-31&surface=latest&period_type=duration&start=2014-09-01&unit=USD&dimensions= Input fundies:NetIncome: -14523 USD (2014-09-01 to 2015-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793218000364/mycloudz-20170831.xml#40733 Filing: 000147793218000364 The citation records this snapshot. The page link may show a newer release later.	−USD 15,773 Exact value Exact value: -15773 USD 2014-09-01 – 2015-08-31: -15773 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2015-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -15773 USD Concept: fundies:OperatingCashFlow Period: 2014-09-01 to 2015-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2015-08-31&surface=latest&period_type=duration&start=2014-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15773 USD (2014-09-01 to 2015-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793216013939/mycloudz-20160831.xml#26610 Filing: 000147793216013939 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-09-01 – 2016-08-31	−USD 35,008 Exact value Exact value: -35008 USD 2015-09-01 – 2016-08-31: -35008 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2016-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -35008 USD Concept: fundies:NetIncome Period: 2015-09-01 to 2016-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2016-08-31&surface=latest&period_type=duration&start=2015-09-01&unit=USD&dimensions= Input fundies:NetIncome: -35008 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793218000364/mycloudz-20170831.xml#40608 Filing: 000147793218000364 The citation records this snapshot. The page link may show a newer release later.	−USD 13,008 Exact value Exact value: -13008 USD 2015-09-01 – 2016-08-31: -13008 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2016-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -13008 USD Concept: fundies:OperatingCashFlow Period: 2015-09-01 to 2016-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2016-08-31&surface=latest&period_type=duration&start=2015-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13008 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793218000364/mycloudz-20170831.xml#43680 Filing: 000147793218000364 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-09-01 – 2017-08-31	−USD 35,850 Exact value Exact value: -35850 USD 2016-09-01 – 2017-08-31: -35850 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2017-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -35850 USD Concept: fundies:NetIncome Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2017-08-31&surface=latest&period_type=duration&start=2016-09-01&unit=USD&dimensions= Input fundies:NetIncome: -35850 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793218000364/mycloudz-20170831.xml#40483 Filing: 000147793218000364 The citation records this snapshot. The page link may show a newer release later.	−USD 58,951 Exact value Exact value: -58951 USD 2016-09-01 – 2017-08-31: -58951 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2017-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -58951 USD Concept: fundies:OperatingCashFlow Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2017-08-31&surface=latest&period_type=duration&start=2016-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58951 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793218000364/mycloudz-20170831.xml#43497 Filing: 000147793218000364 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2017-09-01 – 2018-08-31	−USD 975,524 Exact value Exact value: -975524 USD 2017-09-01 – 2018-08-31: -975524 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2018-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -975524 USD Concept: fundies:NetIncome Period: 2017-09-01 to 2018-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2018-08-31&surface=latest&period_type=duration&start=2017-09-01&unit=USD&dimensions= Input fundies:NetIncome: -975524 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793219007157/gmvp-20190831.xml#60887 Filing: 000147793219007157 The citation records this snapshot. The page link may show a newer release later.	−USD 442,562 Exact value Exact value: -442562 USD 2017-09-01 – 2018-08-31: -442562 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2018-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -442562 USD Concept: fundies:OperatingCashFlow Period: 2017-09-01 to 2018-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2018-08-31&surface=latest&period_type=duration&start=2017-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -442562 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793219007157/gmvp-20190831.xml#76874 Filing: 000147793219007157 The citation records this snapshot. The page link may show a newer release later.	USD 2,467 Exact value Exact value: 2467 USD 2017-09-01 – 2018-08-31: 2467 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GRIDIRON BIONUTRIENTS, INC. · 2018-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Capital Expenditure: 2467 USD Concept: fundies:CapitalExpenditure Period: 2017-09-01 to 2018-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ACapitalExpenditure&period=2018-08-31&surface=latest&period_type=duration&start=2017-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2467 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793219000783/gmvp-20181130.xml#528961 Filing: 000147793219000783 The citation records this snapshot. The page link may show a newer release later.	−USD 445,029 Calculation and evidence -442562 − 2467 USD Exact free cash flow: -445029 USD 2017-09-01 – 2018-08-31: -442562 USD · Inspect Operating Cash Flow · Source 2017-09-01 – 2018-08-31: 2467 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GRIDIRON BIONUTRIENTS, INC. · 2018-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Free cash flow: -445029 USD Concept: free-cash-flow Period: 2017-09-01 to 2018-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -442562 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793219007157/gmvp-20190831.xml#76874 Filing: 000147793219007157 Input fundies:CapitalExpenditure: 2467 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793219000783/gmvp-20181130.xml#528961 Filing: 000147793219000783 The citation records this snapshot. The page link may show a newer release later.
2019 2018-09-01 – 2019-08-31	−USD 170,067 Exact value Exact value: -170067 USD 2018-09-01 – 2019-08-31: -170067 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2019-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -170067 USD Concept: fundies:NetIncome Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2019-08-31&surface=latest&period_type=duration&start=2018-09-01&unit=USD&dimensions= Input fundies:NetIncome: -170067 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793220007273/gmvp-20200831.xml#97362 Filing: 000147793220007273 The citation records this snapshot. The page link may show a newer release later.	−USD 775,929 Exact value Exact value: -775929 USD 2018-09-01 – 2019-08-31: -775929 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2019-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -775929 USD Concept: fundies:OperatingCashFlow Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2019-08-31&surface=latest&period_type=duration&start=2018-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -775929 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793220007273/gmvp-20200831.xml#115482 Filing: 000147793220007273 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-09-01 – 2020-08-31	−USD 2.58 million Exact value Exact value: -2580068 USD 2019-09-01 – 2020-08-31: -2580068 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2020-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -2580068 USD Concept: fundies:NetIncome Period: 2019-09-01 to 2020-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2020-08-31&surface=latest&period_type=duration&start=2019-09-01&unit=USD&dimensions= Input fundies:NetIncome: -2580068 USD (2019-09-01 to 2020-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222000826/gmvp_s1.htm#1731248 Filing: 000147793222000826 The citation records this snapshot. The page link may show a newer release later.	−USD 410,248 Exact value Exact value: -410248 USD 2019-09-01 – 2020-08-31: -410248 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2020-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -410248 USD Concept: fundies:OperatingCashFlow Period: 2019-09-01 to 2020-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2020-08-31&surface=latest&period_type=duration&start=2019-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -410248 USD (2019-09-01 to 2020-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222000826/gmvp_s1.htm#1753066 Filing: 000147793222000826 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-09-01 – 2021-08-31	USD 1.04 million Exact value Exact value: 1039932 USD 2020-09-01 – 2021-08-31: 1039932 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2021-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: 1039932 USD Concept: fundies:NetIncome Period: 2020-09-01 to 2021-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2021-08-31&surface=latest&period_type=duration&start=2020-09-01&unit=USD&dimensions= Input fundies:NetIncome: 1039932 USD (2020-09-01 to 2021-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222009309/ivbt_10k.htm#440115 Filing: 000147793222009309 The citation records this snapshot. The page link may show a newer release later.	−USD 30,405 Exact value Exact value: -30405 USD 2020-09-01 – 2021-08-31: -30405 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2021-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -30405 USD Concept: fundies:OperatingCashFlow Period: 2020-09-01 to 2021-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2021-08-31&surface=latest&period_type=duration&start=2020-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30405 USD (2020-09-01 to 2021-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222009309/ivbt_10k.htm#698083 Filing: 000147793222009309 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2020-09-01 – 2021-08-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GRIDIRON BIONUTRIENTS, INC. · 2021-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2020-09-01 to 2021-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ACapitalExpenditure&period=2021-08-31&surface=latest&period_type=duration&start=2020-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2020-09-01 to 2021-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222009309/ivbt_10k.htm#701725 Filing: 000147793222009309 The citation records this snapshot. The page link may show a newer release later.	−USD 30,405 Calculation and evidence -30405 − 0 USD Exact free cash flow: -30405 USD 2020-09-01 – 2021-08-31: -30405 USD · Inspect Operating Cash Flow · Source 2020-09-01 – 2021-08-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GRIDIRON BIONUTRIENTS, INC. · 2021-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Free cash flow: -30405 USD Concept: free-cash-flow Period: 2020-09-01 to 2021-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30405 USD (2020-09-01 to 2021-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222009309/ivbt_10k.htm#698083 Filing: 000147793222009309 Input fundies:CapitalExpenditure: 0 USD (2020-09-01 to 2021-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793222009309/ivbt_10k.htm#701725 Filing: 000147793222009309 The citation records this snapshot. The page link may show a newer release later.
2022 2021-09-01 – 2022-08-31	−USD 40.88 million Exact value Exact value: -40877813 USD 2021-09-01 – 2022-08-31: -40877813 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2022-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -40877813 USD Concept: fundies:NetIncome Period: 2021-09-01 to 2022-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2022-08-31&surface=latest&period_type=duration&start=2021-09-01&unit=USD&dimensions= Input fundies:NetIncome: -40877813 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#663463 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.	−USD 3.13 million Exact value Exact value: -3127852 USD 2021-09-01 – 2022-08-31: -3127852 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2022-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -3127852 USD Concept: fundies:OperatingCashFlow Period: 2021-09-01 to 2022-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2022-08-31&surface=latest&period_type=duration&start=2021-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3127852 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#690721 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.	USD 3,138 Exact value Exact value: 3138 USD 2021-09-01 – 2022-08-31: 3138 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GRIDIRON BIONUTRIENTS, INC. · 2022-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Capital Expenditure: 3138 USD Concept: fundies:CapitalExpenditure Period: 2021-09-01 to 2022-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ACapitalExpenditure&period=2022-08-31&surface=latest&period_type=duration&start=2021-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3138 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#694459 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.	−USD 3.13 million Calculation and evidence -3127852 − 3138 USD Exact free cash flow: -3130990 USD 2021-09-01 – 2022-08-31: -3127852 USD · Inspect Operating Cash Flow · Source 2021-09-01 – 2022-08-31: 3138 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GRIDIRON BIONUTRIENTS, INC. · 2022-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Free cash flow: -3130990 USD Concept: free-cash-flow Period: 2021-09-01 to 2022-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3127852 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#690721 Filing: 000147793224000223 Input fundies:CapitalExpenditure: 3138 USD (2021-09-01 to 2022-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#694459 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.
2023 2022-09-01 – 2023-08-31	−USD 5.99 million Exact value Exact value: -5988266 USD 2022-09-01 – 2023-08-31: -5988266 USD Inspect Net Income Open source Share or cite Citation for Net Income · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Net Income: -5988266 USD Concept: fundies:NetIncome Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ANetIncome&period=2023-08-31&surface=latest&period_type=duration&start=2022-09-01&unit=USD&dimensions= Input fundies:NetIncome: -5988266 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#662931 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.	−USD 620,195 Exact value Exact value: -620195 USD 2022-09-01 – 2023-08-31: -620195 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Operating Cash Flow: -620195 USD Concept: fundies:OperatingCashFlow Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3AOperatingCashFlow&period=2023-08-31&surface=latest&period_type=duration&start=2022-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -620195 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#690040 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2022-09-01 – 2023-08-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205/explain?concept=fundies%3ACapitalExpenditure&period=2023-08-31&surface=latest&period_type=duration&start=2022-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#693817 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.	−USD 620,195 Calculation and evidence -620195 − 0 USD Exact free cash flow: -620195 USD 2022-09-01 – 2023-08-31: -620195 USD · Inspect Operating Cash Flow · Source 2022-09-01 – 2023-08-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GRIDIRON BIONUTRIENTS, INC. · 2023-08-31 GRIDIRON BIONUTRIENTS, INC. (edgar:1629205) Free cash flow: -620195 USD Concept: free-cash-flow Period: 2022-09-01 to 2023-08-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1629205?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -620195 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#690040 Filing: 000147793224000223 Input fundies:CapitalExpenditure: 0 USD (2022-09-01 to 2023-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1629205/000147793224000223/ivbt_10k.htm#693817 Filing: 000147793224000223 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

40 filings · 1,766 latest values · 1,766 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001629205, 1629205, edgar:1629205

Also known as GRIDIRON BIONUTRIENTS, INC., GridIron BioNutrients, Inc., INNOVATION1 BIOTECH INC., INNOVATION1 BIOTECH INC, INNOVATION1 BIOTECH INC., Innovation1 Biotech Inc., My Cloudz, Inc.

GRIDIRON BIONUTRIENTS, INC.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2022-09-01 – 2023-08-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation